DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,121,000 | -33.2% | 204,430 | +23.7% | 0.01% | -41.2% |
| Q2 2021 | $6,168,000 | +64.6% | 165,251 | +12.7% | 0.02% | +30.8% |
| Q1 2021 | $3,748,000 | +112.2% | 146,587 | +82.9% | 0.01% | +85.7% |
| Q4 2020 | $1,766,000 | +69.8% | 80,155 | +38.7% | 0.01% | +40.0% |
| Q3 2020 | $1,040,000 | +3.1% | 57,804 | +45.5% | 0.01% | -16.7% |
| Q2 2020 | $1,009,000 | +151.6% | 39,715 | +82.1% | 0.01% | +100.0% |
| Q1 2020 | $401,000 | -6.3% | 21,805 | +12.2% | 0.00% | 0.0% |
| Q4 2019 | $428,000 | +83.7% | 19,442 | +20.1% | 0.00% | +50.0% |
| Q3 2019 | $233,000 | – | 16,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |